Skip to main content

Biopolymers Market Size, Growth, Trend, and Forecast (2022-2029) | Increasing Demand for Biopolymers from the Biomedical Sector to Fuel the Industry

Companies covered in biopolymers market are BASF, Danimer Scientific, Total Corbion, FMC Biopolymer A.S, Sigma-Aldrich, Biome Technologies Ltd., Novamont SpA, Nature Works LLC, and other key players.

Pune, India, Oct. 18, 2022 (GLOBE NEWSWIRE) — According to a report by Fortune Business Insights, titled Global Biopolymers Market Size, Share & Industry Analysis, By Type (Polynucleotides, Polypeptides, Polysaccharides), By End-User (Biomedical, Pharmaceuticals, Industrial, Others), And Regional Forecast 2022-2029. The global biopolymers market size is projected to grow speedily on account of the increasing demand for biopolymers from the biomedical sector.

Biopolymers are natural polymers produced by the cells of living organisms. Biopolymers are used in several applications such as in the food industry, pharmaceutical, and biomedical sectors. There has been an increasing demand for biopolymers from the biomedical industry owing to their excellent healing properties. Biopolymers help to cure wounds of any size and shape.

Get a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biopolymers-market-104297

For instance, collagen sponges can be used for the treatment of burns and wounds and other fatal types of injuries. Thus, this is an important factor contributing to the growth of this market. However, the manufacturing cost of biopolymers is relatively high, which is projected to restrict the growth of this market.

The COVID-19 pandemic has not impacted the growth of biopolymers market owing to their wide usage in the pharmaceutical and medical industry for the treatment of wounds, tissue engineering, and drug delivery. Hence, the COVID-19 pandemic has proven beneficial for the growth of this market across several regions.

Report Scope & Segmentation:

Report CoverageDetails
Forecast Period2022-2029
Base Year2021
Historical Data2018-2020
Region CoveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the Rest of the World
Segments CoveredBy Type, End-user and Regional Insights
Biopolymers Industry Growth DriversRising Investments by the Government in the Pharmaceutical Sector to Propel the Market
Rising Demand for Biopolymers from the Packaging Industry to Boost the Market

Competitive Landscape:

Rising Production Capabilities by Key Players to Boost Competition

The leading companies in the biopolymers market are focusing on increasing their production capabilities across several regions due to a high demand for biopolymers in several industries. This has resulted in the increasing competition among key companies which will help them to expand their business horizons and widen their market foothold.

Highlights/Summary:

This research report offers an in-depth study of the driving factors, restraints, and trends related to the       growth of the market. In addition, this report offers a detailed evaluation of the market segments and regional developments in the market. Further, this report also incorporates a comprehensive analysis of the strategies adopted by the leading players to boost their market position.

List of Key Players Covered in the Biopolymers Market Report:

  • BASF
  • Danimer Scientific
  • Total Corbion
  • FMC Biopolymer A.S
  • Sigma-Aldrich
  • Biome Technologies Ltd.
  • Novamont SpA
  • Nature Works LLC

Browse a Detailed Summary of the Research Report with TOC: https://www.fortunebusinessinsights.com/biopolymers-market-104297

Drivers/Restraints:

Rising Demand for Biopolymers from the Packaging Industry to Fuel the Market

There is an increasing demand for biopolymers in the food and packaging industry for edible encapsulation films and coating foods. Further, the biopolymer known as Polylactic Acid (PLA) is mostly used in packaging, which is widely available and biodegradable. Thus, this is a vital factor responsible for the growth of this market.

Regional Insights:

Increasing Government Regulations to Boost European Market Growth

Europe is projected to dominate the biopolymers industry share on account of the strict rules and regulations imposed by the government authorities.

Asia Pacific region is anticipated to grow rapidly in this market due to the increasing industrialization in the countries such as India, China, Japan, and others.

Market Segmentation:

On the basis of type, this market is divided into polynucleotides, polypeptides, and polysaccharides. Based on end-user, the market is classified into biomedical, pharmaceuticals, industrial, and others. By geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Industry Development:

May 2020: BASF and Red Avenue New Materials Group collaborated to manufacture certified compostable polyester in China. The Red Avenue New Materials Group planned to build a new manufacturing facility for PBAT with an annual capacity of 60000 metric tons.

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/biopolymers-market-104297

Read Related Insights:

Lithium-ion Battery Market Size, Share, and regional forecast 2022-2029

Diamond Market Size, Share, and Growth Outlook 2022-2029

Alkaline Battery Market Size, Share, Growth Outlook 2022-2029

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road, Baner,

Pune-411045, Maharashtra, India.     

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Connect us via Social Media Channels:

LinkedIn  Facebook  Twitter Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.